These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18227759)

  • 1. Antibiotic resistance patterns and SDS-PAGE protein profiles of Burkholderia cepacia complex isolates from nosocomial and environmental sources in Venezuela.
    Araque-Calderon Y; Miranda-Contreras L; Rodriguez-Lemoine V; Palacios-Pru EL
    Med Sci Monit; 2008 Feb; 14(2):BR49-55. PubMed ID: 18227759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RecA gene sequence and Multilocus Sequence Typing for species-level resolution of Burkholderia cepacia complex isolates.
    Cesarini S; Bevivino A; Tabacchioni S; Chiarini L; Dalmastri C
    Lett Appl Microbiol; 2009 Nov; 49(5):580-8. PubMed ID: 19732325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and antibiotic susceptibility profiles of Burkholderia cepacia complex in coastal marine environment.
    Maravić A; Skočibušić M; Sprung M; Samanić I; Puizina J; Pavela-Vrančić M
    Int J Environ Health Res; 2012; 22(6):531-42. PubMed ID: 22428949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCR-based identification and characterization of Burkholderia cepacia complex bacteria from clinical and environmental sources.
    Seo ST; Tsuchiya K
    Lett Appl Microbiol; 2004; 39(5):413-9. PubMed ID: 15482431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis.
    Lambiase A; Raia V; Stefani S; Sepe A; Ferri P; Buonpensiero P; Rossano F; Del Pezzo M
    J Microbiol; 2007 Jun; 45(3):275-9. PubMed ID: 17618236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia cepacia complex: beyond pseudomonas and acinetobacter.
    Gautam V; Singhal L; Ray P
    Indian J Med Microbiol; 2011; 29(1):4-12. PubMed ID: 21304187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
    Mahenthiralingam E; Baldwin A; Dowson CG
    J Appl Microbiol; 2008 Jun; 104(6):1539-51. PubMed ID: 18217926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efflux pumps may play a role in tigecycline resistance in Burkholderia species.
    Rajendran R; Quinn RF; Murray C; McCulloch E; Williams C; Ramage G
    Int J Antimicrob Agents; 2010 Aug; 36(2):151-4. PubMed ID: 20399621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disinfection of Burkholderia cepacia complex from non-touch taps in a neonatal nursery.
    Kotsanas D; Brett J; Kidd TJ; Stuart RL; Korman TM
    J Perinat Med; 2008; 36(3):235-9. PubMed ID: 18576933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.
    Bedir Demirdag T; Ozkaya Parlakay A; Aygar IS; Gulhan B; Kanik Yuksek S
    Pediatr Infect Dis J; 2020 May; 39(5):374-378. PubMed ID: 32118858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM; Scott EM
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species distribution and antimicrobial susceptibility of Burkholderia cepacia complex isolates in clinical infections: Experience from a tertiary care hospital, Southern India.
    Kumaresan M; Manoharan M; Sugumar M; Sistla S
    Indian J Med Microbiol; 2024; 49():100613. PubMed ID: 38750965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars.
    Turton JF; Arif N; Hennessy D; Kaufmann ME; Pitt TL
    J Clin Microbiol; 2007 Sep; 45(9):3105-8. PubMed ID: 17626169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Burkholderia cepacia isolation and characterization from hospital infections].
    Cisse MF; Dian YD; Sy OK; Sow AI; Diack-Mbaye A; Signate-Sy A; Samb A
    Dakar Med; 1998; 43(2):144-6. PubMed ID: 10797949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of patients with Burkholderia cepacia bacteremia.
    Huang CH; Jang TN; Liu CY; Fung CP; Yu KW; Wong WW
    J Microbiol Immunol Infect; 2001 Sep; 34(3):215-9. PubMed ID: 11605815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
    Sfeir MM
    J Infect; 2018 Sep; 77(3):166-170. PubMed ID: 30012345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
    Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M
    J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.